【24h】

Food allergy and the gut

机译:食物过敏和肠道

获取原文
获取原文并翻译 | 示例
           

摘要

Food allergy develops as a consequence of a failure in oral tolerance, which is a default immune response by the gut-associated lymphoid tissues to ingested antigens that is modified by the gut microbiota. Food allergy is classified on the basis of the involvement of IgE antibodies in allergic pathophysiology, either as classic IgE, mixed pathophysiology or non-IgE-mediated food allergy. Gastrointestinal manifestations of food allergy include emesis, nausea, diarrhoea, abdominal pain, dysphagia, food impaction, protein-losing enteropathy and failure to thrive. Childhood food allergy has a generally favourable prognosis, whereas natural history in adults is not as well known. Elimination of the offending foods from the diet is the current standard of care; however, future therapies focus on gradual reintroduction of foods via oral, sublingual or epicutaneous food immunotherapy. Vaccines, modified hypoallergenic foods and modification of the gut microbiota represent additional approaches to treatment of food allergy.
机译:食物过敏由于口腔耐受性失败,这是肠道相关淋巴组织的默认免疫应答,以摄入由肠道微生物破坏的抗原。食物过敏根据Ige抗体在过敏病病理学中的参与的基础上进行分类,无论是经典的IgE,混合病理生理学还是非IgE介导的食物过敏。食物过敏的胃肠道表现包括呕吐,恶心,腹泻,腹痛,吞咽困难,食物障碍,蛋白质失去肠病和失败茁壮成长。儿童食物过敏具有一般有利的预后,而成年人的自然历史也不是众所周知的。消除饮食中的违规食物是目前的护理标准;然而,未来的疗法专注于通过口服,舌下或外膜食物免疫治疗逐渐重新引入食物。疫苗,改性的低过敏性食品和肠道微生物的修饰代表了治疗食物过敏的额外方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号